Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. Fundamental Analysis
Bioceres Crop Solutions Corp. (BIOX) shows weak financial fundamentals with a PE ratio of -0.12, profit margin of -92.36%, and ROE of -1.49%. The company generates $0.3B in annual revenue with weak year-over-year growth of -28.30%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -240.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BIOX's fundamental strength across five key dimensions:
Efficiency Score
WeakBIOX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentBIOX trades at attractive valuation levels.
Growth Score
WeakBIOX faces weak or negative growth trends.
Financial Health Score
WeakBIOX carries high financial risk with limited liquidity.
Profitability Score
WeakBIOX struggles to sustain strong margins.
Key Financial Metrics
Is BIOX Expensive or Cheap?
P/E Ratio
BIOX trades at -0.12 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BIOX's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Bioceres Crop Solutions Corp. at 0.42 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 149.03 times EBITDA. This signals the market has high growth expectations.
How Well Does BIOX Make Money?
Net Profit Margin
For every $100 in sales, Bioceres Crop Solutions Corp. keeps $-92.36 as profit after all expenses.
Operating Margin
Core operations generate -2.20 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.49 in profit for every $100 of shareholder equity.
ROA
Bioceres Crop Solutions Corp. generates $-45.99 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bioceres Crop Solutions Corp. generates strong operating cash flow of $74.45M, reflecting robust business health.
Free Cash Flow
Bioceres Crop Solutions Corp. generates strong free cash flow of $68.46M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.08 in free cash annually.
FCF Yield
BIOX converts 2.46% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.42
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.11
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
3.55
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.88
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.49
vs 25 benchmark
ROA
Return on assets percentage
-0.46
vs 25 benchmark
ROCE
Return on capital employed
-0.03
vs 25 benchmark
How BIOX Stacks Against Its Sector Peers
| Metric | BIOX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.12 | 25.14 | Better (Cheaper) |
| ROE | -149.05% | 963.00% | Weak |
| Net Margin | -92.36% | -105282.00% (disorted) | Weak |
| Debt/Equity | 3.55 | 0.52 | Weak (High Leverage) |
| Current Ratio | 0.88 | 6.89 | Weak Liquidity |
| ROA | -45.99% | -3160.00% (disorted) | Weak |
BIOX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bioceres Crop Solutions Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
10.52%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
-981.32%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
206.08%
Industry Style: Cyclical, Commodity, Value
High Growth